Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A

Growing evidence supports the implication of DYRK1A in the development of cognitive deficits seen in Down syndrome (DS) and Alzheimer's disease (AD). We here demonstrate that pharmacological inhibition of brain DYRK1A is able to correct recognition memory deficits in three DS mouse models with...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thu Lan, Duchon, Arnaud, Manousopoulou, Antigoni, Loaëc, Nadège, Villiers, Benoît, Pani, Guillaume, Karatas, Meltem, Mechling, Anna E., Harsan, Laura-Adela, Limanton, Emmanuelle, Bazureau, Jean-Pierre, Carreaux, François, Garbis, Spiros D., Meijer, Laurent, Herault, Yann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176987/
https://www.ncbi.nlm.nih.gov/pubmed/30115750
http://dx.doi.org/10.1242/dmm.035634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176987/
https://www.ncbi.nlm.nih.gov/pubmed/30115750
http://dx.doi.org/10.1242/dmm.035634

Ejemplares similares